Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy.
Microbiology Unit, Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.
Cell Death Dis. 2024 Jun 11;15(6):407. doi: 10.1038/s41419-024-06765-9.
Methicillin-resistant Staphylococcus aureus (MRSA) is the most common causative agent of acute bacterial skin and skin-structure infections (ABSSSI), one of the major challenges to the health system worldwide. Although the use of antibiotics as the first line of intervention for MRSA-infected wounds is recommended, important side effects could occur, including cytotoxicity or immune dysregulation, thus affecting the repair process. Here, we show that the oxazolidinone antibiotic linezolid (LZD) impairs wound healing by aberrantly increasing interleukin 1 β (IL-1β) production in keratinocytes. Mechanistically, LZD triggers a reactive oxygen species (ROS)-independent mitochondrial damage that culminates in increased tethering between the endoplasmic reticulum (ER) and mitochondria, which in turn activates the NLR family pyrin domain-containing 3 (NLRP3) inflammasome complex by promoting its assembly to the mitochondrial surface. Downregulation of ER-mitochondria contact formation is sufficient to inhibit the LZD-driven NLRP3 inflammasome activation and IL-1β production, restoring wound closure. These results identify the ER-mitochondria association as a key factor for NLRP3 activation and reveal a new mechanism in the regulation of the wound healing process that might be clinically relevant.
耐甲氧西林金黄色葡萄球菌(MRSA)是急性细菌性皮肤和皮肤结构感染(ABSSSI)最常见的病原体,是全球卫生系统面临的主要挑战之一。尽管建议将抗生素作为治疗 MRSA 感染伤口的一线干预措施,但可能会出现重要的副作用,包括细胞毒性或免疫失调,从而影响修复过程。在这里,我们表明恶唑烷酮类抗生素利奈唑胺(LZD)通过异常增加角质细胞中白细胞介素 1β(IL-1β)的产生来损害伤口愈合。在机制上,LZD 触发与活性氧(ROS)无关的线粒体损伤,最终导致内质网(ER)和线粒体之间的连接增加,这反过来又通过促进其组装到线粒体表面来激活 NLR 家族吡喃结构域包含 3(NLRP3)炎症小体复合物。下调 ER-线粒体接触形成足以抑制 LZD 驱动的 NLRP3 炎症小体激活和 IL-1β 的产生,从而恢复伤口闭合。这些结果确定了 ER-线粒体关联是 NLRP3 激活的关键因素,并揭示了调节伤口愈合过程的新机制,这可能具有临床相关性。